World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
93
Citations
32599
World Ranking
966
National Ranking
85

Wendy S. Barclay publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Wendy S. Barclay sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 347 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Wendy S. Barclay D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Wendy S. Barclay sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 93 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

What is she best known for?

The fields of study she is best known for:

  • Virus
  • Gene
  • DNA

Wendy S. Barclay mainly focuses on Virology, Virus, Influenza A virus, Viral replication and Influenza A virus subtype H5N1. The various areas that Wendy S. Barclay examines in her Virology study include RNA, Polymerase, H5N1 genetic structure and Pandemic. Her study in the field of Orthomyxoviridae is also linked to topics like RNA silencing.

Her Influenza A virus research includes elements of Hemagglutinin, Gene, Host and Neuraminidase. The Viral replication study which covers RNA-dependent RNA polymerase that intersects with RNA polymerase and Viral transformation. Her Influenza A virus subtype H5N1 study incorporates themes from Viral protein and Effector.

Her most cited work include:

  • Cellular immune correlates of protection against symptomatic pandemic influenza (517 citations)
  • RIG-I detects viral genomic RNA during negative-strand RNA virus infection. (419 citations)
  • Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection (372 citations)

What are the main themes of her work throughout her whole career to date?

Wendy S. Barclay mostly deals with Virology, Virus, Influenza A virus, Pandemic and Influenza A virus subtype H5N1. Her work carried out in the field of Virology brings together such families of science as Polymerase and H5N1 genetic structure. Her studies examine the connections between Virus and genetics, as well as such issues in Microbiology, with regards to Sialic acid.

She interconnects Recombinant virus, Hemagglutinin, Molecular biology, Reverse genetics and Viral shedding in the investigation of issues within Influenza A virus. The concepts of her Pandemic study are interwoven with issues in Odds ratio, Outbreak, Severe acute respiratory syndrome coronavirus 2, Transmission and Vaccination. Her Influenza A virus subtype H5N1 research integrates issues from Reassortant Viruses and Viral load.

She most often published in these fields:

  • Virology (64.19%)
  • Virus (52.56%)
  • Influenza A virus (33.02%)

What were the highlights of her more recent work (between 2018-2021)?

  • Virology (64.19%)
  • Virus (52.56%)
  • Severe acute respiratory syndrome coronavirus 2 (18.60%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Virology, Virus, Severe acute respiratory syndrome coronavirus 2, Pandemic and Coronavirus disease 2019. Her Virology study frequently draws connections to adjacent fields such as Polymerase. Her research integrates issues of Transmission, Cell culture, Gene and Cell biology in her study of Virus.

Her Severe acute respiratory syndrome coronavirus 2 research integrates issues from Seroprevalence, Odds, Public health and Confidence interval. Her Pandemic research includes themes of Odds ratio, Host, Outbreak and Vaccination. Her research integrates issues of Chicken Cells and Viral shedding in her study of Influenza A virus.

Between 2018 and 2021, her most popular works were:

  • The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. (156 citations)
  • Host and viral determinants of influenza A virus species specificity. (122 citations)
  • Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults (105 citations)

In her most recent research, the most cited papers focused on:

  • Virus
  • Gene
  • DNA

Wendy S. Barclay spends much of her time researching Severe acute respiratory syndrome coronavirus 2, Virology, Virus, Pandemic and Coronavirus disease 2019. Her studies in Severe acute respiratory syndrome coronavirus 2 integrate themes in fields like Asymptomatic, High prevalence, Public health and Confidence interval. Her Virology research is multidisciplinary, incorporating perspectives in Infectious disease, Antibody and Immunity.

Influenza A virus and Tissue tropism are subfields of Virus in which her conducts study. Her work carried out in the field of Pandemic brings together such families of science as Odds ratio, Seroconversion and Outbreak. Wendy S. Barclay combines subjects such as T cell and 2019-20 coronavirus outbreak with her study of Coronavirus disease 2019.

Best Publications

  • SARS-CoV-2 variant biology: immune escape, transmission and fitness

    Unknown

  • Mapping the human genetic architecture of COVID-19

    Unknown

  • SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.

    Petra Mlcochova;Steven A Kemp;Steven A Kemp;Mahesh Shanker Dhar;Guido Papa

  • Cellular immune correlates of protection against symptomatic pandemic influenza

    Saranya Sridhar;Shaima Begom;Alison Bermingham;Katja Hoschler

  • Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.

    Anika Singanayagam;Anika Singanayagam;Anika Singanayagam;Seran Hakki;Jake Dunning;Jake Dunning;Kieran J Madon

  • Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

    Unknown

  • The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.

    Thomas P. Peacock;Daniel H. Goldhill;Jie Zhou;Laury Baillon

  • RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

    Jan Rehwinkel;Choon Ping Tan;Choon Ping Tan;Delphine Goubau;Oliver Schulz

  • Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection

    Caroline Goujon;Olivier Moncorgé;Hélène Bauby;Tomas Doyle

  • Host and viral determinants of influenza A virus species specificity.

    Jason S Long;Bhakti Mistry;Stuart M Haslam;Wendy S Barclay

  • A Complicated Message: Identification of a Novel PB1-Related Protein Translated from Influenza A Virus Segment 2 mRNA

    Helen M. Wise;Agnes Foeglein;Jiechao Sun;Rosa Maria Dalton

  • Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study.

    Brian Hanley;Kikkeri N Naresh;Candice Roufosse;Andrew G Nicholson

  • Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice.

    Paul F. McKay;Kai Hu;Anna K. Blakney;Karnyart Samnuan

  • The Origins of SARS-CoV-2: A Critical Review

    Edward C. Holmes;Stephen A. Goldstein;Angela L. Rasmussen;David L. Robertson

  • Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia.

    Luca Braga;Hashim Ali;Ilaria Secco;Elena Chiavacci

  • The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.

    Paul Kellam;Wendy Barclay

  • The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein

    Unknown

  • Infection of human airway epithelium by human and avian strains of influenza a virus.

    Catherine I. Thompson;Wendy S. Barclay;Maria C. Zambon;Raymond J. Pickles

  • Species difference in ANP32A underlies influenza A virus polymerase host restriction

    Jason S. Long;Efstathios S. Giotis;Olivier Moncorgé;Rebecca Frise

  • Identification of a cis-Acting Replication Element within the Poliovirus Coding Region

    Ian Goodfellow;Yasmin Chaudhry;Andrew Richardson;Janet Meredith

  • Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

    Clark D Russell;Cameron J Fairfield;Thomas M Drake;Lance Turtle

  • The mechanism of resistance to favipiravir in influenza

    Daniel H. Goldhill;Daniel H. Goldhill;Aartjan J. W. te Velthuis;Robert A. Fletcher;Pinky Langat

  • Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.

    Maria Prendecki;Maria Prendecki;Candice Clarke;Jonathan Brown;Alison Cox

  • Investigating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Surface and Air Contamination in an Acute Healthcare Setting During the Peak of the Coronavirus Disease 2019 (COVID-19) Pandemic in London.

    Jie Zhou;Jonathan A Otter;Jonathan A Otter;James R Price;James R Price;Cristina Cimpeanu

Frequent Co-Authors

Ara Darzi
Ara Darzi Imperial College London
Christl A. Donnelly
Christl A. Donnelly University of Oxford
Paul Elliott
Paul Elliott Imperial College London
Deborah Ashby
Deborah Ashby Imperial College London
Maria Zambon
Maria Zambon Public Health England
Peter J. Diggle
Peter J. Diggle Lancaster University
Peter J. M. Openshaw
Peter J. M. Openshaw Imperial College London
Paul Kellam
Paul Kellam Imperial College London
Aeron C. Hurt
Aeron C. Hurt Roche (Switzerland)
Michael A. Skinner
Michael A. Skinner Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare degrees offer valuable pathways to enhance knowledge and career prospects. Many professionals transition into these fields through specialized online programs designed for various backgrounds. For example, non-nurses looking to enter the nursing field can explore online absn programs for non nurses. These accelerated programs allow a faster track to nursing licensure while building a strong foundation in patient care.

Additionally, students seeking quicker entry into nursing might consider accelerated nursing programs. These programs cater to individuals aiming to earn a Bachelor of Science in Nursing in a condensed timeframe without compromising educational quality.

For those focused on practical nursing roles, accredited lpn programs easy to get into provide accessible entry points into the healthcare workforce. Licenses Practical Nurse programs emphasize hands-on training and patient interaction, which can complement Immunology expertise.

Finally, advancing further in nursing specialties can be facilitated by exploring what is the easiest np program. Nurse Practitioner degrees open doors to advanced clinical roles and leadership positions that intersect with Immunology research and practice.

Best Scientists Citing Wendy S. Barclay

Trending Scientists

Recently Published Articles